Current findings for Zappy Health
Monthly prices and starter prices describe different commitments
The reviewed semaglutide page lists $249 billed monthly. Its three-month starter offer is advertised at $159 per month, with $477 paid upfront, for first-time GLP-1 users when clinically appropriate. The tirzepatide page lists $349 billed monthly and a three-month starter offer of $279 per month, totaling $837 upfront. State and clinical eligibility apply.
These are advertised compounded-plan terms, not quotes for approved Wegovy or Zepbound. Ask which offer applies to your prescription, whether all medication is sent together, and what happens after the starter supply.
Sources: Compounded Semaglutide | From $159/mo | Zappy Health · Compounded Semaglutide | From $159/mo | Zappy Health
Longer plans change the amount paid at once
Zappy lists three- and six-month options with lower monthly equivalents and a single upfront payment. The semaglutide page gives $687 for three months and $1,254 for six; the tirzepatide page gives $987 and $1,794. The pages say all vials ship together on these offers.
Request a written explanation of the number of vials, dose progression, unopened storage and the deadline after opening each vial. A large total quantity does not establish how long an opened vial can safely be used.
Sources: Compounded Semaglutide | From $159/mo | Zappy Health · Compounded Semaglutide | From $159/mo | Zappy Health · FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss | FDA
Clinical support is part of the advertised plan
The product pages describe monthly virtual visits and support. The semaglutide page identifies The Pharmacy Hub as its dispensing pharmacy. Confirm the actual pharmacy assigned to your prescription and its license in your state; an advertised network or testing statement is not an independent audit of your medication.
Sources: Compounded Semaglutide | From $159/mo | Zappy Health · Compounded Semaglutide | From $159/mo | Zappy Health · Locate a State-Licensed Online Pharmacy | FDA
Cancellation and refund depend on processing status
The refund policy permits cancellation and a refund before the pharmacy processes medication. It describes a $30 restocking deduction after the order enters shipping but before tracking is assigned, and no refund after a tracking number is assigned. Pausing later charges does not refund a shipment already processed.
The product pages also use a shorter non-refundable-after-processing statement. Resolve how those statements apply to your particular order before paying, especially for a prepaid supply.
Sources: Refund Policy - Zappy Health · Compounded Semaglutide | From $159/mo | Zappy Health
Tirzepatide: what the name does and does not tell you
Zepbound and Mounjaro contain tirzepatide, a medicine that activates GIP and GLP-1 receptors. Zepbound is labeled for weight reduction and long-term maintenance in eligible adults and for moderate-to-severe obstructive sleep apnea in adults with obesity. Mounjaro is labeled for type 2 diabetes in adults and children aged 10 years and older, and for reducing major cardiovascular events in adults with type 2 diabetes who are at high risk for these events. Those uses do not make Mounjaro an FDA-approved weight-management brand.
The approved products are injections. A compounded tirzepatide tablet or dissolvable preparation is not FDA-approved Zepbound or Mounjaro; their clinical results do not validate that alternative formulation. Ask for the exact drug, route, ingredients, and dispensing pharmacy. This page’s medication-specific URL does not confirm that Zappy Health currently offers it.
Sources: Zepbound prescribing information · Mounjaro prescribing information
Compounded medicines are not FDA-approved. FDA recommends them only when a patient’s medical needs cannot be met by an approved medicine. Its April 2026 update says semaglutide and tirzepatide are not on the drug shortage list or the 503B bulks list. Patient-specific exceptions and other legal conditions matter; a “personalized” label, vitamin additive, or pharmacy registration does not by itself establish compliance or effectiveness.
Sources: FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss | FDA · FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize | FDA
Safety questions for the prescribing clinician
The approved products cited here have a boxed warning about thyroid C-cell tumors in rodents; whether they cause these tumors in humans is unknown. Their contraindications include a personal or family history of medullary thyroid carcinoma (MTC), MEN 2, and specified serious allergic reactions. These are specific conditions, rather than a statement that every thyroid disorder rules out treatment. Review the exact product label with your clinician.
Tell the clinician about severe stomach-emptying problems, pancreatitis or gallbladder history, kidney concerns, diabetic eye disease, and every medicine or supplement you use. The labels do not recommend these products in severe gastroparesis. Insulin and medicines such as sulfonylureas can increase low-blood-sugar risk when used with them; adjustments belong with the prescriber. These examples do not replace the full safety review.
Zepbound should be discontinued when pregnancy is recognized. Tirzepatide can reduce the effectiveness of oral hormonal contraceptives: the Zepbound and Mounjaro labels advise a non-oral method or an added barrier method for four weeks after starting and for four weeks after each dose increase. Ask the clinician about pregnancy planning and breastfeeding for the exact prescription.
Sources: Zepbound prescribing information · Mounjaro prescribing information
Severe abdominal pain that does not go away, with or without vomiting, can be a pancreatitis warning; the labels instruct patients to stop the medicine and seek medical help promptly. Repeated vomiting or inability to keep fluids down also needs prompt assessment. For trouble breathing or swallowing, swelling of the face, tongue or throat, or collapse suggesting a serious allergic reaction, call 911 or your local emergency number immediately. Your provider should explain urgent and after-hours care before treatment starts.
Sources: Zepbound prescribing information · Mounjaro prescribing information · Anaphylaxis: MedlinePlus Medical Encyclopedia
Tell the anesthesia or procedure team about treatment before surgery or deep sedation. Do not independently combine GLP-1 products, shorten injection intervals or restart an old high dose after a break. Procedure planning and side effects and warning symptoms explain the questions to resolve with the care team.
Sources: Zepbound prescribing information · Mounjaro prescribing information
Questions to resolve before paying Zappy Health
- Am I eligible for the starter offer, and what is the full first charge?
- Which vials arrive together, and what instructions apply to each unopened and opened vial?
- Which exact medication and formulation would my prescription specify, and which pharmacy would dispense it?
- What are the total first and renewal payments, and does the advertised monthly price require prepayment?
- Who manages side effects and dose changes, and what follow-up care is included?
- What is the cancellation deadline, and which fees remain non-refundable?
Ask for a written quote showing the medication, care or membership fee, labs, shipping, supplies, first payment, renewal payment, and cancellation cutoff. A monthly equivalent on a prepaid plan is different from paying that amount every month. A four-week supply and a calendar-month subscription also have different annual totals.
Verify your prescriber’s license and the dispensing pharmacy with the relevant state boards. Check that the pharmacy named on your prescription matches the pharmacy on the package. If injectable medication arrives warm or inadequately refrigerated, FDA advises against using it; contact the dispensing pharmacy for instructions. Avoid products sold as research chemicals or without a prescription.
Sources: FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss | FDA
How to use this profile
This is a review of public information, not a hands-on clinical test or a verified patient review. We do not assign star ratings to clinical care, medication quality, response time, or shipping. An advertised benefit remains a provider claim unless independent evidence supports the specific claim. Confirm current availability, state eligibility, and the final terms directly before enrolling.
Read our source and correction policy and commercial disclosure. Medical review has not been completed.